If a patient exhibits inflammation due to an overactive NF-κB pathway secondary to chronic TNF-α signaling in intestinal epithelial cells, which intervention targets the core problem?

A)Administering antihistamines to reduce vasodilation

B)Prescribing NSAIDs inhibiting COX-1/-2 enzymes

C)Applying a specific IKK inhibitor locally✓

D)Increasing dietary fiber to modify microbiota

💡 Explanation

A specific IKK inhibitor would target the NF-κB activation directly, because IKK phosphorylates IκB, leading to NF-κB activation. Therefore, inhibiting IKK prevents NF-κB driven transcription of inflammatory cytokines, rather than generally suppressing COX enzymes or only indirectly affecting the pathway.

🏆 Up to £1,000 monthly prize pool

Ready for the live challenge? Join the next global round now.
*Terms apply. Skill-based competition.

⚡ Enter Arena

If a patient exhibits inflammation due to an overactive NF-κB pathway secondary to chronic TNF-α signaling in intestinal epithelial cells, which intervention targets the core problem?

💡 Explanation

Related Questions